Skip to main content
SpringerLink
Log in

Letter to the Editor re: Semiquantitative Parameters in PSMA-Targeted PET Imaging with [18F]DCFPyL: Impact of Tumor Burden on Normal Organ Uptake

  • Letter to the Editor
  • Published:
Molecular Imaging and Biology Aims and scope Submit manuscript

A Correction to this article was published on 06 January 2020

This article has been updated

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1.
Fig. 2.

Change history

  • 06 January 2020

    The article was updated to correct the following errors due to an error in production:

References

  1. Werner RA, Bundschuh RA, Bundschuh L et al (2019) Semiquantitative parameters in PSMA-targeted PET imaging with [18F]DCFPyL: impact of tumor burden on normal organ uptake. Mol Imaging Biol. https://doi.org/10.1007/s11307-019-01375-w

  2. Yadav MP, Ballal SRK, Sahoo SN et al (2019) Radioligand therapy with 177Lu-PSMA for metastatic castration-resistant prostate cancer: a systematic review and meta-analysis. Am J Roentgenol 213:275–285

    Article  Google Scholar 

  3. Gaertner FC, Halabi K, Ahmadzadehfar H et al (2017) Uptake of PSMA-ligands in normal tissues is dependent on tumor load in patients with prostate cancer. Oncotarget 8:55094–55103

    Article  Google Scholar 

  4. Jansen BHE, Yaqub M, Voortman J et al (2019) Simplified methods for quantification of 18F-DCFPyL uptake in patients with prostate cancer. J Nucl Med. https://doi.org/10.2967/jnumed.119.227520

  5. Jansen BHE, Kramer GM, Cysouw MCF et al (2019) Healthy tissue uptake of 68Ga-prostate specific membrane antigen (PSMA), 18F-DCFPyL, 18F-Fluoromethylcholine (FCH) and 18F-Dihydrotestosterone (FDHT). J Nucl Med. https://doi.org/10.2967/jnumed.118.222505

  6. Beauregard JM, Hofman MS, Kong G, Hicks RJ (2012) The tumour sink effect on the biodistribution of 68Ga-DOTA-octreotate: implications for peptide receptor radionuclide therapy. Eur J Nucl Med Mol Imaging 39:50–56

    Article  CAS  Google Scholar 

  7. Ilan E, Velikyan I, Sandstrom M et al (2019) Tumor-to-blood ratio for assessment of somatostatin receptor density in neuroendocrine tumors using 68Ga-DOTATOC and 68Ga-DOTATATE. J Nucl Med. https://doi.org/10.2967/jnumed.119.228072

  8. Wahl RL, Jacene H, Kasamon Y, Lodge MA (2009) From RECIST to PERCIST: evolving considerations for PET response criteria in solid tumors. J Nucl Med 50(Suppl 1):122S–150S

    Article  CAS  Google Scholar 

Download references

Acknowledgments

We acknowledge Dr. Michael Morris for his contributions in our collaborative study on [18F]DCFPyL response assessment.

Author information

Authors and Affiliations

  1. Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Radiology and Nuclear Medicine, Cancer Center Amsterdam, De Boelelaan, 1117, Amsterdam, Netherlands

    M. C. F. Cysouw, B. H. E. Jansen, M. Yaqub, O. S. Hoekstra, R. Boellaard & D. E. Oprea-Lager

  2. Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Urology, Cancer Center Amsterdam, De Boelelaan, 1117, Amsterdam, Netherlands

    B. H. E. Jansen, A. N. Vis & R. J. A. van Moorselaar

  3. Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Medical Oncology, Cancer Center Amsterdam, De Boelelaan, 1117, Amsterdam, Netherlands

    J. Voortman

Authors
  1. M. C. F. Cysouw
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. B. H. E. Jansen
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M. Yaqub
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. J. Voortman
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. A. N. Vis
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. R. J. A. van Moorselaar
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. O. S. Hoekstra
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. R. Boellaard
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. D. E. Oprea-Lager
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to M. C. F. Cysouw.

Ethics declarations

Conflict of Interest

The authors declare that they have no conflict of interest. The [18F]DCFPyL PET-CT scans shown were funded by the Prostate Cancer Foundation.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

The original version of this article was revised. Full information regarding the corrections made can be found in the erratum/correction for this article.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Cysouw, M.C.F., Jansen, B.H.E., Yaqub, M. et al. Letter to the Editor re: Semiquantitative Parameters in PSMA-Targeted PET Imaging with [18F]DCFPyL: Impact of Tumor Burden on Normal Organ Uptake. Mol Imaging Biol 22, 15–17 (2020). https://doi.org/10.1007/s11307-019-01438-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11307-019-01438-y

Search

Navigation